We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients

 

OLFUS-VIPES Results

Latest News

Monthly information regarding the total number of voting rights and total number of shares of the Company 

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

Documentation

20F- Form 2016